Log in to save to my catalogue

Characterisation of concurrent use of prescription opioids and benzodiazepine/Z-drugs in Alberta, Ca...

Characterisation of concurrent use of prescription opioids and benzodiazepine/Z-drugs in Alberta, Ca...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2520bac4b4bf4491a3fe0abe9ed4f28c

Characterisation of concurrent use of prescription opioids and benzodiazepine/Z-drugs in Alberta, Canada: a population-based study

About this item

Full title

Characterisation of concurrent use of prescription opioids and benzodiazepine/Z-drugs in Alberta, Canada: a population-based study

Publisher

England: British Medical Journal Publishing Group

Journal title

BMJ open, 2019-09, Vol.9 (9), p.e030858-e030858

Language

English

Formats

Publication information

Publisher

England: British Medical Journal Publishing Group

More information

Scope and Contents

Contents

ObjectiveThe objective of this study is to characterise concurrent use of benzodiazepine receptor modulators and opioids among prescription opioid users in Alberta in 2017.DesignA population based retrospective study.SettingAlberta, Canada, in the year 2017.ParticipantsAll individuals in Alberta, Canada, with at least one dispensation record from a...

Alternative Titles

Full title

Characterisation of concurrent use of prescription opioids and benzodiazepine/Z-drugs in Alberta, Canada: a population-based study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_2520bac4b4bf4491a3fe0abe9ed4f28c

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2520bac4b4bf4491a3fe0abe9ed4f28c

Other Identifiers

ISSN

2044-6055

E-ISSN

2044-6055

DOI

10.1136/bmjopen-2019-030858

How to access this item